WEC
ONCE

Winslow Evans & Crocker’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Winslow Evans & Crocker’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-60
Closed -$6K – 1168
2019
Q3 		$6K Hold
60
– – ﹤0.01% 958
2019
Q2 		$8K Hold
60
– – ﹤0.01% 906
2019
Q1 		$8K Hold
60
– – ﹤0.01% 903
2018
Q4 		$4K Hold
60
– – ﹤0.01% 988
2018
Q3 		$4K Hold
60
– – ﹤0.01% 997
2018
Q2 		$6K Hold
60
– – ﹤0.01% 939
2018
Q1 		$4K Hold
60
– – ﹤0.01% 940
2017
Q4 		$3.09K Buy
+60
New +$4.31K ﹤0.01% 984

Winslow Evans & Crocker's ONCE Position: Q4 2019 in Review

Winslow Evans & Crocker sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 60 shares — an estimated $6K sold.

Winslow Evans & Crocker first reported a position in ONCE in Q4 2017 and held it in 8 quarters. The position peaked at $8K in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Winslow Evans & Crocker reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Winslow Evans & Crocker sold 60 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $6K.
  • Winslow Evans & Crocker first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
  • Winslow Evans & Crocker's Spark Therapeutics, Inc. Common Stock position peaked at $8K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Winslow Evans & Crocker's 13F filing for Q4 2019, filed 14 Jan 2020.